COVID-19 2022 update: transition of the pandemic to the endemic phase
M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …
Here, we review the current state of research into the disease with focus on its history …
SARS-CoV-2 reinfections and long COVID in the post-omicron phase of the pandemic
We are reviewing the current state of knowledge on the virological and immunological
correlates of long COVID, focusing on recent evidence for the possible association between …
correlates of long COVID, focusing on recent evidence for the possible association between …
Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in
children and young people (CYP,< 18 years old), but quantifying the risk of death is …
children and young people (CYP,< 18 years old), but quantifying the risk of death is …
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19
Introduction Loss-of-function TLR7 variants have been recently reported in a small number
of males to underlie strong predisposition to severe COVID-19. We aimed to determine the …
of males to underlie strong predisposition to severe COVID-19. We aimed to determine the …
Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona
X Solanich, R Rigo-Bonnin, VD Gumucio… - Journal of clinical …, 2021 - Springer
Background It is important to predict which patients infected by SARS-CoV-2 are at higher
risk of life-threatening COVID-19. Several studies suggest that neutralizing auto-antibodies …
risk of life-threatening COVID-19. Several studies suggest that neutralizing auto-antibodies …
SARS-CoV-2 variants and clinical outcomes: a systematic review
IR Mendiola-Pastrana, E Lopez-Ortiz… - Life, 2022 - mdpi.com
Background: From the start of the COVID-19 pandemic, new SARS-CoV-2 variants have
emerged that potentially affect transmissibility, severity, and immune evasion in infected …
emerged that potentially affect transmissibility, severity, and immune evasion in infected …
COVID-19 due to the B. 1.617. 2 (Delta) variant compared to B. 1.1. 7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Abstract The Delta (B. 1.617. 2) variant was the predominant UK circulating SARS-CoV-2
strain between May and December 2021. How Delta infection compares with previous …
strain between May and December 2021. How Delta infection compares with previous …
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
M Sabater Molina, E Nicolas Rocamora, AI Bendicho… - PloS one, 2022 - journals.plos.org
Background Infection by the SARS-Cov-2 virus produces in humans a disease of highly
variable and unpredictable severity. The presence of frequent genetic single nucleotide …
variable and unpredictable severity. The presence of frequent genetic single nucleotide …
Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
Background: The Delta (B. 1.617. 2) SARS-CoV-2 variant was the predominant UK
circulating strain between May and November 2021. We investigated whether COVID-19 …
circulating strain between May and November 2021. We investigated whether COVID-19 …
The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature
Background COVID-19 is associated with several risk factors such as distinct ethnicities
(genetic ancestry), races, sexes, age, pre-existing comorbidities, smoking, and genetics. The …
(genetic ancestry), races, sexes, age, pre-existing comorbidities, smoking, and genetics. The …